However, SIRT1 expression is increased in various hematological malignancies, including chronic myeloid leukemia (CML)22,23, some subtypes of AML24, B-ALL25, and T cell leukemia and lymphoma26,27. Here, SIRT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.